CLAIM #12093 · Bristol-Myers Squibb Company (BMY) · 2024Q4 earnings call · Feb 6, 2025 · due Dec 31, 2026
“We have the potential for 15 or more registrational trials that will read out by the end of next year.”
Chris Boerner · CEO
PENDING
graded after results covering Dec 31, 2026 are reported
How to check this claim
Look at: Number of registrational (pivotal/Phase 3) trial readouts disclosed by the company
It came true if: Count of registrational trial readouts announced >= 15 by end of 2026
Where: Company press releases, pipeline updates, and quarterly earnings calls/presentations
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2024Q4 earnings call.